Overbrook Management Corp’s AbbVie ABBV Stock Holding History

Overbrook Management Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11.2M	Sell	42,968 -1,311	-3%	-$336K	1.75%	18
2026 Q2	$11.1M	Sell	44,279 -10,865	-20%	-$2.34M	1.68%	21
2026 Q1	$12M	Buy	55,144 +13,085	+31%	+$2.9M	2.27%	17
2025 Q4	$9.61M	Buy	+42,059	New	+$9.58M	1.66%	21
2020 Q1	–	Sell	-9,570	Closed	-$847K	–	70
2019 Q4	$847K	Buy	9,570 +500	+6%	+$41.5K	0.25%	46
2019 Q3	$687K	Hold	9,070	–	–	0.17%	50
2019 Q2	$660K	Sell	9,070 -26,922	-75%	-$2.12M	0.14%	50
2019 Q1	$2.9M	Hold	35,992	–	–	0.62%	31
2018 Q4	$3.32M	Sell	35,992 -23	-0.1%	-$2.02K	0.77%	29
2018 Q3	$3.41M	Hold	36,015	–	–	0.65%	35
2018 Q2	$3.34M	Sell	36,015 -449	-1%	-$43.9K	0.63%	31
2018 Q1	$3.45M	Sell	36,464 -352	-1%	-$38.7K	0.71%	30
2017 Q4	$3.56M	Buy	36,816 +163	+0.4%	+$15.4K	0.72%	30
2017 Q3	$3.26M	Sell	36,653 -8,014	-18%	-$610K	0.74%	28
2017 Q2	$3.24M	Sell	44,667 -8,981	-17%	-$604K	0.7%	31
2017 Q1	$3.5M	Sell	53,648 -3,270	-6%	-$206K	0.76%	30
2016 Q4	$3.56M	Sell	56,918 -720	-1%	-$43.9K	0.78%	29
2016 Q3	$3.63M	Sell	57,638 -5,110	-8%	-$331K	0.84%	28
2016 Q2	$3.88M	Sell	62,748 -525	-0.8%	-$32K	0.81%	28
2016 Q1	$3.61M	Sell	63,273 -150	-0.2%	-$8.36K	0.78%	29
2015 Q4	$3.76M	Sell	63,423 -265	-0.4%	-$15.3K	0.66%	26
2015 Q3	$3.46M	Buy	63,688 +90	+0.1%	+$5.86K	0.53%	31
2015 Q2	$4.27M	Buy	63,598 +1,623	+3%	+$106K	0.65%	30
2015 Q1	$3.63M	Sell	61,975 -1,758	-3%	-$106K	0.59%	33
2014 Q4	$4.17M	Buy	63,733 +1,180	+2%	+$74.4K	0.84%	23
2014 Q3	$3.61M	Sell	62,553 -450	-0.7%	-$25K	0.57%	34
2014 Q2	$3.56M	Sell	63,003 -2,090	-3%	-$110K	0.63%	36
2014 Q1	$3.35M	Sell	65,093 -3,604	-5%	-$182K	0.64%	38
2013 Q4	$3.63M	Sell	68,697 -4,745	-6%	-$233K	0.69%	37
2013 Q3	$3.29M	Buy	73,442 +1,020	+1%	+$45.2K	0.76%	39
2013 Q2	$2.99M	Buy	+72,422	New	+$3.17M	0.72%	38

Other funds holding ABBV

HCM

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Overbrook Management Corp's ABBV Position: Q3 2026 in Review

Overbrook Management Corp reduced its AbbVie (ABBV) stake by 3% in Q3 2026, selling an estimated $336K and leaving 42,968 shares worth $11.2M. The position accounts for 1.75% of the portfolio, ranked #18.

Overbrook Management Corp first reported a position in ABBV in Q2 2013 and has held it in 31 quarters since. The position peaked at $12M in Q1 2026. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Overbrook Management Corp held 42,968 shares of AbbVie worth $11.2M as of Q3 2026.
Overbrook Management Corp sold 1,311 AbbVie shares in Q3 2026, an estimated $336K.
AbbVie made up 1.75% of Overbrook Management Corp's portfolio in Q3 2026, its #18 holding.
Overbrook Management Corp first reported a position in AbbVie in Q2 2013 and has held it in 31 quarters since.
Overbrook Management Corp's AbbVie position peaked at $12M in Q1 2026.
246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Overbrook Management Corp's 13F filing for Q3 2026, filed 8 Oct 2026.